has been cited by the following article(s):
[1]
|
Total neoadjuvant therapy for locally advanced gastric cancer and esophagogastric junction adenocarcinoma: study protocol for a prospective, multicenter, single-arm, phase II clinical trial
BMC Gastroenterology,
2022
DOI:10.1186/s12876-022-02440-5
|
|
|